fluconazole has been researched along with Rhabdomyolysis in 8 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
| Excerpt | Relevance | Reference |
|---|---|---|
| " When intravenous fluconazole was added for treating a fungal infection, rhabdomyolysis developed 2 weeks later." | 7.83 | Rhabdomyolysis caused by the moderate CYP3A4 inhibitor fluconazole in a patient on stable atorvastatin therapy: a case report and literature review. ( Chang, HJ; Hsiao, SH; Hsieh, TH; Kao, SM; Wu, TJ; Yeh, PY, 2016) |
| " After administration of atorvastatin, amiodarone, and fluconazole, rhabdomyolysis developed with electrolyte disturbances (hyperphosphatemia, hyopcalcemia) and a massive increase in creatine kinase and myoglobin." | 7.77 | [Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole]. ( Bruggisser, M; Franz, CC; Krähenbühl, S; Rätz Bravo, AE, 2011) |
| "Rhabdomyolysis is a potential adverse consequence of statin therapy." | 5.35 | Rhabdomyolysis induced by simvastatin-fluconazole combination. ( Abuzetun, JY; Hazin, R; Porter, J; Suker, M, 2008) |
| " After administration of atorvastatin, amiodarone, and fluconazole, rhabdomyolysis developed with electrolyte disturbances (hyperphosphatemia, hyopcalcemia) and a massive increase in creatine kinase and myoglobin." | 3.77 | [Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole]. ( Bruggisser, M; Franz, CC; Krähenbühl, S; Rätz Bravo, AE, 2011) |
| "Exertional rhabdomyolysis is a common condition with potentially life-threatening consequences; early recognition can prevent severe downstream complications." | 1.51 | Exertional Rhabdomyolysis in a Long-Distance Migrant. ( Andreae, MC; Fernando, DB; McVane, BA; Strayer, RJ, 2019) |
| "Rhabdomyolysis is a serious complication of statin treatment." | 1.46 | Weakness and pain in arms and legs · dark urine · history of vertebral osteomyelitis · Dx? ( Brateanu, A; Charokopos, A; Muhammad, T; Surbhi, S, 2017) |
| "Rhabdomyolysis was suspected and both drugs were discontinued." | 1.43 | [Myopathy in a patient during simvastatin and fluconazole treatment]. ( Junker, P; Lydolph, MC; Pedersen, JK; Somnier, F, 2016) |
| "Rhabdomyolysis is a potential adverse consequence of statin therapy." | 1.35 | Rhabdomyolysis induced by simvastatin-fluconazole combination. ( Abuzetun, JY; Hazin, R; Porter, J; Suker, M, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McVane, BA | 1 |
| Andreae, MC | 1 |
| Fernando, DB | 1 |
| Strayer, RJ | 1 |
| Hsiao, SH | 1 |
| Chang, HJ | 1 |
| Hsieh, TH | 1 |
| Kao, SM | 1 |
| Yeh, PY | 1 |
| Wu, TJ | 1 |
| Pedersen, JK | 1 |
| Lydolph, MC | 1 |
| Somnier, F | 1 |
| Junker, P | 1 |
| Charokopos, A | 1 |
| Muhammad, T | 1 |
| Surbhi, S | 1 |
| Brateanu, A | 1 |
| Findling, O | 1 |
| Meier, N | 1 |
| Sellner, J | 1 |
| Nedeltchev, K | 1 |
| Arnold, M | 1 |
| Franz, CC | 1 |
| Bruggisser, M | 1 |
| Krähenbühl, S | 1 |
| Rätz Bravo, AE | 1 |
| Kahri, J | 1 |
| Valkonen, M | 1 |
| Bäcklund, T | 1 |
| Vuoristo, M | 1 |
| Kivistö, KT | 1 |
| Hazin, R | 1 |
| Abuzetun, JY | 1 |
| Suker, M | 1 |
| Porter, J | 1 |
8 other studies available for fluconazole and Rhabdomyolysis
| Article | Year |
|---|---|
Exertional Rhabdomyolysis in a Long-Distance Migrant.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Clindamycin; Creatine Kinase; Female; Fluconazole; Human | 2019 |
Rhabdomyolysis caused by the moderate CYP3A4 inhibitor fluconazole in a patient on stable atorvastatin therapy: a case report and literature review.
Topics: Aged; Atorvastatin; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Fluconazole; Human | 2016 |
[Myopathy in a patient during simvastatin and fluconazole treatment].
Topics: Aged; Antifungal Agents; Drug Interactions; Female; Fluconazole; Humans; Hydroxymethylglutaryl-CoA R | 2016 |
Weakness and pain in arms and legs · dark urine · history of vertebral osteomyelitis · Dx?
Topics: Adult; Arm; Cytochrome P-450 CYP3A Inhibitors; Diagnosis, Differential; Drug Interactions; Drug-Rela | 2017 |
Clinical reasoning: rhabdomyolysis after combined treatment with simvastatin and fluconazole.
Topics: Aged; Anticholesteremic Agents; Antifungal Agents; Candidiasis; Diagnosis, Differential; Drug Therap | 2008 |
[Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticholesteremic Agents; Antifungal Agents; Atorvastatin; | 2011 |
Rhabdomyolysis in a patient receiving atorvastatin and fluconazole.
Topics: Antifungal Agents; Atorvastatin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Sy | 2005 |
Rhabdomyolysis induced by simvastatin-fluconazole combination.
Topics: Acute Kidney Injury; Aged; Antifungal Agents; Biomarkers; Creatine Kinase; Drug Interactions; Drug T | 2008 |